White Paper
Conducting pediatric trials in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Related insights
More from our insights
Blog
SGLT2 inhibitors as renoprotective agents for pediatric patients living with chronic kidney disease
Explore the benefits of SGLT2 inhibitors as renoprotective agents for pediatric patients. Fortrea’s blog provides insights into diabetes medication and renal protection.
Read more
Case Study
Implementing a novel approach for recruiting a seasonal pediatric vaccine mega-trial
This case study demonstrates how Fortrea developed a novel approach to successfully delivery a large, industry-sponsored Phase III clinical trial to prevent hospitalization of infants due to a seasonal and dangerous illness.
Download Case Study
White Paper
MASH trial design
Development pathways and trial design for liver cirrhosis secondary to MASH
Download White Paper
Blog
Empowering young voices in pediatric clinical trials: Fortrea’s commitment to child rights and participation
Learn about the experiences of the young participants involved in the clinical trials.
Read more
Blog
Rare Disease Day: Celebrating progress and hope for the future
Join Fortrea in celebrating Rare Disease Day, highlighting progress in medical research and hope for the future.
Read more